By G HossainPosted on April 30, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. Avalyn beats expectations with $300M debut Post navigation Lilly clocks 56% revenue increase in Q1 but declining prices stunt growthCAR T therapy developer Autolus laying off 13% of workforce